Options Expiration Weighing on Dendreon

June 15, 2007 · Filed Under General 

by Jon C. Ogg
24/7 Wall St.

Dendreon (DNDN) has seen a lot of the old hyperactive trading volume come out of the stock now that it is post-FDA panel review and post-ASCO. The stock has barely traded 2 million shares so far this morning and there was only 1 day this week where shares almost traded 10 million shares.

The drag today outside of less ‘event trading’ is that today is also options expiration date. The June $7.50 Strike Price is trying to act as a magnet as that is the most active strike, the closest strike, and generally the one with the highest open interest. As of last look, the open interest for the $7.50 strike was more than 76,000 in the June-07 $7.50 calls and more than 48,000 in the June-07 $7.50 puts.

Continue article at 247WallSt.com

Related Reading:
- Cell Genesys Should Not Trade With Dendreon!
- Dendreon Taps Financing Sooner Than Expected
- Analysts Continue to Dump on Dendreon

247WallSt.com is a regular contributor to BioHealthInvestor.com
____________________________

Comments

Leave a Reply

You must be logged in to post a comment.

    Subscribe to BioHealth Investor - Biotech and Medical Business Blog BioHealth Investor RSS Feed